Kari Erichsen

Summary

Affiliation: Haukeland University Hospital
Country: Norway

Publications

  1. ncbi request reprint Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease
    K Erichsen
    Department of Medicine, University of Bergen, Bergen, Norway
    Aliment Pharmacol Ther 22:831-8. 2005
  2. ncbi request reprint Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease
    K Erichsen
    Institute of Medicine, Haukeland University Hospital, University of Bergen, Bergen Norway
    Scand J Gastroenterol 38:543-8. 2003
  3. ncbi request reprint Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis
    Kari Erichsen
    Department of Medicine, Haukeland University Hospital, Bergen, Norway
    Inflamm Bowel Dis 11:744-8. 2005
  4. ncbi request reprint Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease
    Kari Erichsen
    Department of Medicine, Haukeland University Hospital, Bergen, Norway
    Scand J Gastroenterol 40:1058-65. 2005
  5. pmc Effect of live Salmonella Ty21a in Dextran Sulfate Sodium-induced Colitis
    Gunnar Nysœter
    Department of Medicine, Section for Gastroenterology, Haukeland University Hospital, Bergen, Norway
    Drug Target Insights 2:221-8. 2007
  6. ncbi request reprint Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases
    Christoph Gasche
    Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria
    Inflamm Bowel Dis 13:1545-53. 2007

Detail Information

Publications6

  1. ncbi request reprint Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease
    K Erichsen
    Department of Medicine, University of Bergen, Bergen, Norway
    Aliment Pharmacol Ther 22:831-8. 2005
    ..Iron deficiency is a common complication of inflammatory bowel disease. Oral iron therapy may reinforce intestinal tissue injury by catalyzing production of reactive oxygen species...
  2. ncbi request reprint Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease
    K Erichsen
    Institute of Medicine, Haukeland University Hospital, University of Bergen, Bergen Norway
    Scand J Gastroenterol 38:543-8. 2003
    ..We investigated the effect of ferrous iron on disease activity and plasma antioxidant status in patients with active Crohn disease...
  3. ncbi request reprint Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis
    Kari Erichsen
    Department of Medicine, Haukeland University Hospital, Bergen, Norway
    Inflamm Bowel Dis 11:744-8. 2005
    ..We studied the effects of low-dose oral ferrous fumarate on intestinal inflammation and plasma redox status in dextran sulfate sodium (DSS)-induced colitis in rats...
  4. ncbi request reprint Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease
    Kari Erichsen
    Department of Medicine, Haukeland University Hospital, Bergen, Norway
    Scand J Gastroenterol 40:1058-65. 2005
    ..The effects of oral ferrous fumarate and intravenous iron sucrose on clinical disease activity and plasma redox status were investigated in patients with inflammatory bowel disease (IBD)...
  5. pmc Effect of live Salmonella Ty21a in Dextran Sulfate Sodium-induced Colitis
    Gunnar Nysœter
    Department of Medicine, Section for Gastroenterology, Haukeland University Hospital, Bergen, Norway
    Drug Target Insights 2:221-8. 2007
    ..We hypothesised that an oral vaccine based on live Salmonella typhi would be well tolerated and could even attenuate dextran sulfate sodium (DSS) induced colitis in rats, an animal model of IBD...
  6. ncbi request reprint Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases
    Christoph Gasche
    Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria
    Inflamm Bowel Dis 13:1545-53. 2007
    ..It therefore needs appropriate attention and specific care...